Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus
about
Phospholipid scramblase 1 is secreted by a lipid raft-dependent pathway and interacts with the extracellular matrix protein 1 in the dermal epidermal junction zone of human skinExtracellular matrix protein 1 inhibits the activity of matrix metalloproteinase 9 through high-affinity protein/protein interactionsPediatric Lichen Sclerosus: A Review of the Literature and Management RecommendationsInteraction between cartilage oligomeric matrix protein and extracellular matrix protein 1 mediates endochondral bone growth.The co-occurrence of lichen sclerosus et atrophicus and celiac disease.Unusual remodeling of the hyalinization band in vulval lichen sclerosus by type V collagen and ECM 1 protein.Calcineurin antagonists in vulvar lichen sclerosus.The molecular basis of lipoid proteinosis: mutations in extracellular matrix protein 1.Evaluation of Symptoms and Prevention of Cancer in Menopause: The Value of Vulvar Exam.Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer.The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.Eosinophils in lichen sclerosus et atrophicus.Lichen sclerosus in women: a review.Extracellular matrix protein 1, a direct targeting molecule of parathyroid hormone-related peptide, negatively regulates chondrogenesis and endochondral ossification via associating with progranulin growth factor.Expression of extracellular matrix protein 1 (ECM1) in human skin is decreased by age and increased upon ultraviolet exposure.Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer.
P2860
Q24300930-B19F5057-8AF6-4ADB-8663-3114D2ED8384Q24306471-BF0508B9-A402-4453-8E54-D51D871C31EEQ28067462-994673A7-8CFE-489E-8385-295535813993Q33823788-F638AA36-EF7E-41D1-BBCA-0BE7FA59585FQ34909353-04EFD43C-D149-493C-8AA1-EAF5BFF01188Q35666635-73A59EA9-D56D-41E7-8780-7FB1C9309B81Q36531703-BE659B94-2223-4EC0-B968-9D97282C982FQ36967337-77D7A001-6F74-4538-AB3A-6DE5731B6725Q37432569-BB67BED5-CE00-479E-8840-6CE675404C3AQ37536632-5AF68691-46C4-40F0-981B-B9CE3A631B2AQ37706192-8435E59D-BCDB-485E-874A-0EF374258DBDQ38543652-D9490D85-A41C-453D-A879-777F068CEDB4Q39404801-4D632F3F-44D9-42EB-BAD7-35333DC41D93Q41764817-28E5112B-5C31-4E50-B7ED-138C5B8E0617Q42489873-4568B225-52E4-4F24-A43D-4FDA7E7E1D39Q42660638-8E53B4C1-D4C4-4CE7-94F4-1BFEE97E023A
P2860
Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 in lichen sclerosus
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@ast
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@en
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@nl
type
label
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@ast
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@en
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@nl
prefLabel
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@ast
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@en
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@nl
P2093
P2860
P356
P1476
Development of antigen-specifi ...... protein 1 in lichen sclerosus
@en
P2093
Andrew P South
Balbir S Bhogal
David D'Cruz
Fenella Wojnarowska
Fumio Kaneko
Graham J Hughes
John A McGrath
Kirti Mepani
Martin M Black
P2860
P304
P356
10.1172/JCI200420373
P407
P577
2004-06-01T00:00:00Z